Acalabrutinib
| Acalabrutinib | |
|---|---|
| Term | Acalabrutinib |
| Short definition | Acalabrutinib (uh-KA-luh-BROO-tih-nib) medicine used to treat adults with chronic lymphocytic leukemia or small lymphocytic lymphoma and adults with mantle cell lymphoma who have been treated with at least one other therapy. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Acalabrutinib - (pronounced) (uh-KA-luh-BROO-tih-nib) medicine used to treat adults with chronic lymphocytic leukemia or small lymphocytic lymphoma and adults with mantle cell lymphoma who have been treated with at least one other therapy. It is also being studied in the treatment of other types of cancer. Acalabrutinib blocks a protein called BTK, which can help prevent cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also called Calquence
External links
- Medical encyclopedia article on Acalabrutinib
- Wikipedia's article - Acalabrutinib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski